How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

David Malan: At first, it was very experimental. ChatGPT came out in November of 2022, and starting in the spring of 2023, we ...

The US-China race for artificial intelligence dominance has entered a new phase: using AI to build better AI. Leading AI companies in the United States and China are increasingly focused on deploying ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

A recursive JSON-to-relational conversion engine written in Python that analyzes semi-structured JSON data at runtime, infers a relational schema, generates PostgreSQL tables, creates ...

What vector and graph databases actually do, why AI agents made both matter, which vendors offer UK hosting, and when the Postgres you already run is enough.

CRESSim-Neo is a C++17 simulation engine with optional Python bindings. Third-party C++ dependencies (including Diligent Engine, pybind11, and GLFW) are tracked as in-tree git submodules; a normal ...